Chistiakov Dimitry A, Orekhov Alexander N, Bobryshev Yuri V
Department of Molecular Genetic Diagnostics and Cell Biology, Division of Laboratory Medicine, Institute of Pediatrics, Research Center for Children's Health, 119991 Moscow, Russia.
Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow 125315, Russia; Department of Biophysics, Biological Faculty, Moscow State University, Moscow 119991, Russia; Institute for Atherosclerosis Research, Skolkovo Innovative Center, Moscow 121609, Russia.
J Mol Cell Cardiol. 2016 Aug;97:47-55. doi: 10.1016/j.yjmcc.2016.05.007. Epub 2016 May 12.
Expression of microRNA (miR)-126 is enriched in endothelial cells (ECs) and endothelial progenitor cells (EPCs). MiR-126 is considered a master regulator of physiological angiogenesis. In embryonic vasculogenesis, this miRNA is involved in induction of angiogenic signaling, supports differentiation of embryonic stem cells to EPCs and ECs, and promotes EC maturation. However, in mature ECs and adult EPCs, miR-126 contributes to vascular homeostasis by inhibiting angiogenesis and maintaining the quiescent endothelial phenotype associated with increased vascular integrity and inhibited proliferation and motility. In a case of vessel injury and/or hypoxia, miR-126 up-regulation activates EPCs and ECs and contributes to vascular healing and neovessel formation. Indeed, miR-126 exhibits vasculoprotective and atheroprotective properties. The promising regenerative and proangiogenic potential of this miRNA will be helpful for development of cardioprotective strategies and cardiovascular repair therapies of myocardial infarction, heart failure, and other cardiovascular pathology.
微小RNA(miR)-126在血管内皮细胞(ECs)和内皮祖细胞(EPCs)中表达丰富。MiR-126被认为是生理性血管生成的主要调节因子。在胚胎血管生成过程中,这种微小RNA参与血管生成信号的诱导,支持胚胎干细胞向EPCs和ECs的分化,并促进EC成熟。然而,在成熟的ECs和成年EPCs中,miR-126通过抑制血管生成和维持与血管完整性增加以及增殖和运动受抑制相关的静止内皮表型,对血管稳态起作用。在血管损伤和/或缺氧的情况下,miR-126上调激活EPCs和ECs,并有助于血管愈合和新血管形成。事实上,miR-126具有血管保护和抗动脉粥样硬化特性。这种微小RNA具有的有前景的再生和促血管生成潜力将有助于制定心肌梗死、心力衰竭和其他心血管疾病的心脏保护策略和心血管修复疗法。